PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase

MLA

Eduardo Anguita, et al. “PTCH1 Is a Reliable Marker for Predicting Imatinib Response in Chronic Myeloid Leukemia Patients in Chronic Phase.” PLoS ONE, vol. 12, no. 7, Jan. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....173bc9f081eed1d38f0becbe19905359&authtype=sso&custid=ns315887.

APA

Eduardo Anguita, Pilar Llamas, Valentín García-Gutiérrez, Santiago Osorio, Ignacio Mahillo-Fernández, Luis Felipe Casado, Carmen Burgaleta, Juan M. Alonso-Domínguez, Ismael Buño, Pedro Sánchez-Godoy, Juan Luis Steegmann, Alicia Arenas, Joaquin Martinez-Lopez, Rafael Del Orbe, María Teresa Gómez-Casares, Rocio N. Salgado, Francisca Ferrer-Marín, & Rosa Ayala. (2017). PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase. PLoS ONE, 12(7).

Chicago

Eduardo Anguita, Pilar Llamas, Valentín García-Gutiérrez, Santiago Osorio, Ignacio Mahillo-Fernández, Luis Felipe Casado, Carmen Burgaleta, et al. 2017. “PTCH1 Is a Reliable Marker for Predicting Imatinib Response in Chronic Myeloid Leukemia Patients in Chronic Phase.” PLoS ONE 12 (7). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....173bc9f081eed1d38f0becbe19905359&authtype=sso&custid=ns315887.